Detection of deletions at 7q11.23 in Williams-Beuren syndrome by polymorphic markers

INTRODUCTION: Williams-Beuren syndrome (WBS; OMIM 194050) is caused by a hemizygous contiguous gene microdeletion at 7q11.23. Supravalvular aortic stenosis, mental retardation, overfriendliness, and ocular and renal abnormalities comprise typical symptoms in WBS. Although fluorescence in situ hybridization is widely used for diagnostic confirmation, microsatellite DNA markers are considered highly informative and easily manageable. OBJECTIVES: This study aimed to test the microsatellite markers for the diagnosis of Williams-Beuren syndrome, to determine the size and parental origin of microdeletion, compare the clinical characteristics between patients with different sizes of the deletion and parental origin. METHODS: We studied 97 patients with clinical diagnosis of Williams-Beuren syndrome using five microsatellite markers: D7S1870, D7S489, D7S613, D7S2476 and D7S489_A. RESULTS AND DISCUSSION: Using five markers together, the result was informative in all patients. The most informative marker was D7S1870 (78.4%), followed by D7S613 (75.3%), D7S489 (70.1%) and D7S2476 (62.9%). The microdeletion was present in 84 (86.6%) patients and absent in 13 (13.4%) patients. Maternal deletions were found in 52.4% of patients and paternal deletions in 47.6% of patients. The observed size of deletions was 1.55 Mb in 76/ 84 patients (90.5%) and 1.84 Mb in 8/84 patients (9.5%). SVAS as well as ocular and urinary abnormalities were more frequent in the patients with a deletion. There were no clinical differences in relation to either the size or parental origin of the deletion. CONCLUSION: Using these five selected microsatellite markers was informative in all patients, thus can be considered an alternative method for molecular diagnosis in Williams-Beuren syndrome

Cytogenomic assessment of the diagnosis of 93 patients with developmental delay and multiple congenital abnormalities: The Brazilian experience

OBJECTIVE: The human genome contains several types of variations, such as copy number variations, that can generate specific clinical abnormalities. Different techniques are used to detect these changes, and obtaining an unequivocal diagnosis is important to understand the physiopathology of the diseases. The objective of this study was to assess the diagnostic capacity of multiplex ligation-dependent probe amplification and array techniques for etiologic diagnosis of syndromic patients. METHODS: We analyzed 93 patients with developmental delay and multiple congenital abnormalities using multiplex ligation-dependent probe amplifications and arrays. RESULTS: Multiplex ligation-dependent probe amplification using different kits revealed several changes in approximately 33.3% of patients. The use of arrays with different platforms showed an approximately 53.75% detection rate for at least one pathogenic change and a 46.25% detection rate for patients with benign changes. A concomitant assessment of the two techniques showed an approximately 97.8% rate of concordance, although the results were not the same in all cases. In contrast with the array results, the MLPA technique detected ∼70.6% of pathogenic changes. CONCLUSION: The obtained results corroborated data reported in the literature, but the overall detection rate was higher than the rates previously reported, due in part to the criteria used to select patients. Although arrays are the most efficient tool for diagnosis, they are not always suitable as a first-line diagnostic approach because of their high cost for large-scale use in developing countries. Thus, clinical and laboratory interactions with skilled technicians are required to target patients for the most effective and beneficial molecular diagnosis

FGFR4 Profile as a Prognostic Marker in Squamous Cell Carcinoma of the Mouth and Oropharynx

Background: Fibroblast growth factor receptor 4 (FGFR4) is a member of a receptor tyrosine kinase family of enzymes involved in cell cycle control and proliferation. A common single nucleotide polymorphism (SNP) Gly388Arg variant has been associated with increased tumor cell motility and progression of breast cancer, head and neck cancer and soft tissue sarcomas. The present study evaluated the prognostic significance of FGFR4 in oral and oropharynx carcinomas, finding an association of FGFR4 expression and Gly388Arg genotype with tumor onset and prognosis. Patients and Methods: DNA from peripheral blood of 122 patients with oral and oropharyngeal squamous cell carcinomas was used to determine FGFR4 genotype by PCR-RFLP. Protein expression was assessed by immunohistochemistry (IHC) on paraffin-embedded tissue microarrays. Results: Presence of allele Arg388 was associated with lymphatic embolization and with disease related premature death. In addition, FGFR4 low expression was related with lymph node positivity and premature relapse of disease, as well as disease related death. Conclusion: Our results propose FGFR4 profile, measured by the Gly388Arg genotype and expression, as a novel marker of prognosis in squamous cell carcinoma of the mouth and oropharynx.FAPESPFAPESP [04/15022-0, 04/12054-9

The prevalence of risk for hearing impairment in newborns with congenital syphilis in a newborn hearing screening program (NHS)

ObjectiveTo study the prevalence of risk for hearing impairment in neonates with congenital syphilis in a newborn hearing screening program.Study designThe study design is retrospective, documentary, and is cross-sectional. The sample consisted of newborns who were born between January 2019 and December 2021 and who underwent neonatal hearing screening in a public maternity hospital. Demographic data and the presence and specification of risk indicators for hearing impairment (RIHL) were collected. In retest cases, the results and the final score were also collected. For data analysis, the Kruskal–Wallis and Conover-Iman post-hoc tests were used, comparing the groups that passed and failed the hearing screening that had RIHL, using a significance level of p of <0.5.ResultsAmong the RIHL observed in the sample, prematurity was more frequent in newborns who passed the screening (55.26%) than in those who failed the test (45.67%). Congenital syphilis was the ninth most frequent RIHL (8.04%) among the newborns who passed the test and the 15th factor (3.03%), with the highest occurrence in those who failed the hearing screening. When comparing the two groups (pass and fail), we found significant differences (p < 0.05) between them.ConclusionCongenital syphilis was the ninth risk indicator for the most common hearing impairment and, in isolation, did not present a risk for failure in neonatal hearing screening. Notably, congenital syphilis can cause late hearing loss during child development. Thus, there is an indication of audiological monitoring of these neonates

Investigation of the copy number variation (CNVs) in patients with congenital anomalies (CA) and mental retardation (MR) using the MLPA (Multiplex Ligation-dependent Probe Amplification) technique

INTRODUÇÃO: Os desequilíbrios genômicos constituem causa frequente de abortamento, anomalias congênitas (AC) e atraso de desenvolvimento neuropsicomotor (ADNPM). O aprimoramento de novas técnicas de diagnóstico citogenômico, como por exemplo, a MLPA (Multiplex Ligation-dependent Probe Amplification) e a triagem ampla do DNA utilizando arrays, mostraram que a alteração no número normal de cópias genômicas (CNVs) influencia na patogenicidade dos fenótipos em diversas síndromes. OBJETIVOS: Com isso, os objetivos do presente estudo foram identificar CNVs em pacientes com MC e ADNPM utilizando a técnica de MLPA e, a partir dos resultados alterados, aplicar da técnica de array para a identificação de possíveis rearranjos complexos, além de associar as alterações moleculares encontradas com o fenótipo dos pacientes. MÉTODOS: Participaram do estudo 416 pacientes com MC e ADNPM. As amostras de DNA foram analisadas utilizando a técnica de MLPA com kits comerciais para as principais síndromes de microdeleções (P064) e regiões subteloméricas (P036 e P070). Dois kits de MLPA específicos para as regiões 7q11.23 (P029) e 22q11.2 (P250) também foram utilizados para complementar a identificação de CNVs atípicas. Entre os casos que apresentavam alterações pela técnica de MLPA, 15 pacientes foram submetidos à técnica de array, utilizando três diferentes plataformas: Agilent SurePrint G3 Genoma Humano microarray 180 K, HumanCytoSNP-12 BeadChip, CytoScan(TM) HD array 6.0 Affymetrix®. RESULTADOS: A análise molecular pela técnica de MLPA possibilitou a detecção de microdeleções e/ou microduplicações em 97 pacientes sendo que: em 46 pacientes foi possível encontrar alterações utilizando apenas o kit P064 (microdeleções), em 34 pacientes utilizando apenas os kits P036 e P070 (regiões subteloméricas) e em quatro pacientes só foi possível identificar a alteração utilizando outro kit de MLPA (P250), específico para alterações genômicas em 22q11.2. Rearranjos complexos, envolvendo mais de três cromossomos, foram observados em 10 pacientes. DISCUSSÃO: A MLPA permitiu detectar CNVs em 97/416 pacientes (23,3%), sendo uma técnica ideal para ser aplicada em pacientes com sinais fenotípicos inespecíficos. Algumas alterações genômicas encontradas estão relacionadas também com alterações específicas, como a presença de malformação cardíaca ou convulsões. E em outros casos a alta variabilidade fenotípica pode ser associada a um conjunto de CNVs consideradas patogênicas. Além disso, a inclusão de outra técnica de triagem, com maior cobertura do genoma permitiu detectar rearranjos complexos antes não observados mesmo em síndromes bem descritas como as síndromes de midrodeleções 7q11.23 e 22q11.2. CONCLUSÃO: A MLPA com kits combinados, por possuir maior abrangência de regiões detectadas e menor custo, é uma ferramenta valiosa para ser utilizada como um teste de triagem diagnósticaINTRODUCTION: Genomic imbalances are the most common cause of miscarriage, congenital anomalies (CA) and mental retardation (MR). With the improvement of new cytogenomics diagnostic techniques, such as the MLPA (Multiplex Ligation-dependent Probe Amplification) and the array techniques, it have been shown that changes in the normal gene copy number influence the pathogenic variability of phenotypes in different syndromes. AIMS: The aims of the present study were to identify CNVs in patients with CM and RM using the MLPA technique and, from the abnormalities results, to apply the array methodology for the identification of complex rearrangements. Furthermore, the study aimed to associate the alterations found by molecular techniques with the phenotype of patients. METHODS: 416 patients with CM and RM participated in the study. The samples were analysed by MLPA technique with commercial kits for the main microdeletion syndromes (P064) and subtelomeric regions (P036 and P070). Two more MLPA kits for specific regions 7q11.23 (P029) and 22q11.2 (P250) were used to confirm the altered results and to complement some results with the identification of atypical abnormalities. From the patients who presented abnormalities by MLPA technique, 15 underwent by microarray-based comparative genomic hybridization (CGH-array) technique, using three different platform: Agilent SurePrint G3 Human Genome microarray 180 kb, HumanCytoSNP -12 BeadChip, CytoScan(TM) HD ® and Affymetrix 6.0. RESULTS: The molecular analysis by MLPA technique allowed the detection of microdeletions and/or microduplications in 97 patients. In 46 patients it was possible to find genomic alteration using only MLPA kit P064 and in 34 patients using only the subtelomeric kits P036 and P070. For four patients it was only possible to identify the genomic abnormalities using another specific MLPA kit (P250), involving the 22q11.2 region. Complex rearrangements involving more than three chromosomes were detected in 10 patients. DISCUSSION: The MLPA technique was capable of detecting CNVs in 97/416 (23,3%) of patients, being an ideal technique to be applied in patients with non-specific signs phenotypic. Some genomic alterations found are, also related to specific changes, such as the presence of cardiac malformation or convulsions. In other cases, the high phenotypic variability may be associated to certain group of pathogenic CNVs. Moreover, the inclusion of additional screening method, with greater coverage, allowed the detection of complex rearrangements not seen before even in syndromes as well described microdeletions syndromes on 7q11.23 and 22q11.2 regions. CONCLUSION: The MLPA technique can be a valuable tool used as a molecular screening test, because it has greater coverage and lower cost of detected region

Analysis of microsatellite DNA markers in the diagnosis of Williams- Beuren syndrome

INTRODUÇÃO: A síndrome de Williams-Beuren (SWB; OMIM #194050) é causada por microdeleções em hemizigose de genes contíguos na região 7q11.23. Fácies típico, estenose aórtica supravalvar (EASV), deficiência intelectual, personalidade amigável e hiperacusia constituem as principais características da SWB. A deleção mais freqüente é de 1,55Mb, porém deleção de 1,84Mb também já foi descrita. Embora a técnica de hibridização in situ por fluorescência (FISH) ser amplamente utilizada na detecção da deleção, os marcadores microssatélites são considerados altamente informativos e de fácil manejo. OBJETIVOS: Testar os marcadores microssatélites para o diagnóstico da SWB, determinar o tamanho e origem parental da microdeleção, comparar as características clínicas entre os pacientes com diferentes tamanhos da deleção e origem parental. MÉTODOS: Foram estudados 97 pacientes com diagnóstico clínico de SWB utilizando cinco marcadores microssatélites: D7S1870, D7S489, D7S613, D7S2476 e D7S489_A. A partir do DNA genômico dos probandos e de seus genitores, foi realizada reação em cadeia da polimerase (PCR), seguida de eletroforese em gel de poliacrilamida desnaturante (uréia, com 7,5 M) e os resultados visualizados com coloração de prata. RESULTADOS E DISCUSSÃO: Com cinco marcadores juntos, o resultado foi informativo em todos os pacientes. O marcador mais informativo foi D7S1870 (78,4%), seguido por D7S613 (75,3%), D7S489 (70,1%) e D7S2476 (62,9%). A deleção foi encontrada em 84 (86,6%) pacientes e sua ausência em 13 (13,4%) pacientes. A deleção de 1,55 Mb foi observada em 76/84 pacientes (90,5%) e 1,84 Mb em 8/84 pacientes (9,5%). A origem parental da deleção foi materna em 44/84 pacientes (52,4%) e paterna em 40/84 pacientes (47,6%). Alterações oculares foram mais freqüentes em pacientes com deleção. Não houve diferença nos achados clínicos entre o tamanho ou a origem parental da deleção, exceto para EASV, presente em maior freqüência nos pacientes com deleção paterna. Os resultados por marcadores microssatélites foram concordantes com FISH positivos, no entanto, em dois pacientes com FISH negativos, a microdeleção foi detectada apenas pelos marcadores. CONCLUSÃO: O uso de cinco marcadores microssatélites selecionados foi informativo em todos os pacientes. Em dois casos, os marcadores foram mais eficientes que FISH, portanto pode ser considerado um método alternativo para o diagnóstico molecular da SWBINTRODUCTION: Williams-Beuren syndrome (WBS; OMIM 194050) is caused by hemizygous contiguous gene microdeletions at 7q11.23. Typical facies, supravalvular aortic stenosis (SVAS), mental retardation, overfriendliness and hiperacusis comprise typical symptoms in WBS. The most common deletion is 1.55 Mb, however 1.84 Mb deletion also has been described. Although fluorescence in situ hybridization (FISH) is widely used in the detection of deletion, microsatellite markers are considered highly informative and easily manageable. PURPOSE: Test the microsatellite markers for the diagnosis of WBS, to determine the size and parental origin of microdeletion, compare the clinical characteristics between patients with different sizes of the deletion and parental origin. METHODS: We studied 97 patients with clinical diagnosis of WBS using five microsatellite markers: D7S1870, D7S489, D7S613, D7S2476 and D7S489_A. From the genomic DNA of probands and their parents was performed polymerase chain reaction (PCR), followed by electrophoresis on denaturing polyacrylamide gel (urea, 7.5 M) and the results visualized with silver staining. RESULTS AND DISCUSSION: Using five markers together, the result was informative in all patients. The most informative marker was D7S1870 (78.4%) followed by D7S613 (75.3%), D7S489 (70.1%) and D7S2476 (62.9%). The deletion was found in 84 (86.6%) patients and absent in 13 (13.4%) patients. The deletion of 1.55 Mb was observed in 76/84 patients (90.5%) and 1.84 Mb in 8 / 84 patients (9.5%). The parental origin was maternal in 44/84 patients (52.4%) and paternal in 40/84 patients (47.6%). Abnormalities ocular were more frequent in the patients with a deletion. There were no clinical differences in relation to either the size or parental origin of the deletion, except for SVAS, present in more frequency in the patients with paternal deletion. The results for microsatellite markers were concordant with FISH positive, however, in two patients with negative FISH, the microdeletion was detected only by the markers. CONCLUSION: Using these five selected microsatellite markers was informative in all patients. In two cases, the markers were more efficient than FISH, thus can be considered an alternative method for molecular diagnosis in SW

Investigation of copy number variation in children with conotruncal heart defects

Background: Congenital heart defects (CHD) are the most prevalent group of structural abnormalities at birth and one of the main causes of infant morbidity and mortality. Studies have shown a contribution of the copy number variation in the genesis of cardiac malformations. Objectives: Investigate gene copy number variation (CNV) in children with conotruncal heart defect. Methods: Multiplex ligation-dependent probe amplification (MLPA) was performed in 39 patients with conotruncal heart defect. Clinical and laboratory assessments were conducted in all patients. The parents of the probands who presented abnormal findings were also investigated. Results: Gene copy number variation was detected in 7/39 patients: 22q11.2 deletion, 22q11.2 duplication, 15q11.2 duplication, 20p12.2 duplication, 19p deletion, 15q and 8p23.2 duplication with 10p12.31 duplication. The clinical characteristics were consistent with those reported in the literature associated with the encountered microdeletion/microduplication. None of these changes was inherited from the parents. Conclusions: Our results demonstrate that the technique of MLPA is useful in the investigation of microdeletions and microduplications in conotruncal congenital heart defects. Early diagnosis of the copy number variation in patients with congenital heart defect assists in the prevention of morbidity and decreased mortality in these patients

Estresse em crianças e adolescentes com Síndrome de Williams-Beuren em idade escolar

Síndrome de Williams-Beuren é uma doença de múltiplos órgãos causada por microdeleção de 25 genes no cromossomo 7 (q11.23), sugerindo uma vulnerabilidade ao estresse. Objetivamos determinar se crianças e adolescentes com síndrome de Williams-Beuren apresentam níveis elevados de estresse. Avaliamos 40 indivíduos em idade escolar, com diagnóstico de síndrome de Williams-Beuren e grupo controle. Os instrumentos utilizados: Escala de Estresse Infantil (ESI), Escala de Inteligência para Crianças (WISC), Escala de Inteligência para Adultos (WAIS) e um questionário semiestruturado. No grupo com o SWB, 50% tinham altos níveis de estresse em comparação com 28,6% no grupo controle, diferença altamente significativa estatisticamente (p 0,140). Indivíduos com síndrome de Williams mostram índice elevado de estresse. Este estudo destaca a necessidade de orientação sobre a síndrome a pais e gestão escolar, com foco na redução de possíveis fatores ambientais estressantes

Role of SNAP29, LZTR1 and P2RXL1 genes on immune regulation in a patient with atypical 0.5 Mb deletion in 22q11.2 region

Inst Med Integral Prof Fernando Figueira IMIP, Translat Res Lab Prof CA Hart, BR-50070550 Recife, PE, BrazilUniv São Paulo, Fac Med, Hosp Clin, Med Invest Lab LIM 36, São Paulo, BrazilUniv São Paulo, Fac Med, Med Genet Unit, Inst Crianca, São Paulo, BrazilUniv São Paulo, Dept Pathol, Citogen Lab LIM 03, São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Morphol & Genet, São Paulo, BrazilInst Med Integral Prof Fernando Figueira IMIP, Clin Immunol Unit, BR-50070550 Recife, PE, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Morphol & Genet, São Paulo, BrazilWeb of Scienc